COVID-19 Pandemic Coverage
XTalks
SEPTEMBER 14, 2020
The University of Oxford/AstraZeneca partnership, in turn, is testing a viral-vectored coronavirus vaccine that again expresses the spike protein of SARS-CoV-2 virus. Pfizer is actually working with Germany’s BioNTech on mRNA vaccines against the coronavirus, using strands of mRNA to generate protective antibodies.
92 
Let's personalize your content